SOPHiA Genetics, a cloud-native software company and a leader in data-driven medicine, has expanded an existing program in Spain to increase access to local testing for homologous recombination deficiency (HRD) throughout the country.   The expansion of the program, supported by AstraZeneca Spain and its network throughout the country, aims to make this vital testing available to thousands more patients in the country. Origins of the Collaborative Program The program from SOPHiA Genetics ...